Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?-MedSci.cn - 梅斯（MedSci）

Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

Saker, K; Pozzetto, B; Bal, A; Valette, M; Fassier, JB; Saade, C; Trabaud, MA; Trouillet-Assant, S

Trouillet-Assant, S (通讯作者)，Univ Lyon, Hosp Civils Lyon, Int Ctr Res Infectiol, Team VirPath,Univ Claude Bernard Lyon 1,Bernard L, F-69007 Lyon, France.

CLINICAL CHEMISTRY, 2022; 68 (7): 984

科室
- - 订阅+
  - 更多科室
工具
服务